1.31

11.19% -0.165

After Hours: 1.35 0.04 +3.05%

Redhill Biopharma Ltd Adr (RDHL)

Overview News Price History Discussions Forecast Stock Split

Redhill Biopharma Ltd Adr stock is traded at $1.31, with a volume of 213.89K. It is down -11.19% in the last 24 hours and down -32.47% over the past month. Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Previous Close:

$1.475

Open:

$1.51

24h Volume:

213.89K

Relative Volume:

0.43

Market Cap:

$3.01M

Revenue:

$35.75M

Net Income/Loss:

$11.57M

P/E Ratio:

-0.3441

EPS:

-3.8069

Net Cash Flow:

$-26.25M

1W Performance:

-28.42%

1M Performance:

-32.47%

6M Performance:

-77.83%

1Y Performance:

-86.36%

1-Day Range:

$1.30

$1.51

1-Week Range:

$1.30

$1.87

52-Week Range:

$1.30

$20.28

Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile

Name

Redhill Biopharma Ltd Adr

Sector

Healthcare (1161)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

Address

Employee

Twitter

@RedHillBio

Next Earnings Date

2025-03-31

Latest SEC Filings

RDHL's Discussions on Twitter

Compare RDHL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RDHL Redhill Biopharma Ltd Adr	1.31	3.39M	35.75M	11.57M	-26.25M	-3.8069
ZTS Zoetis Inc	145.79	66.25B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	13.72	42.95B	30.08B	710.16M	4.45B	0.2182
HLN Haleon Plc Adr	9.43	43.30B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.45	19.30B	16.54B	-1.64B	749.00M	-1.45
NBIX Neurocrine Biosciences Inc	128.23	13.53B	2.41B	305.80M	492.20M	2.95

Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-31-21	Initiated	Cantor Fitzgerald	Overweight
May-18-21	Initiated	H.C. Wainwright	Buy
Sep-11-20	Initiated	BTIG Research	Buy
Jul-12-19	Upgrade	WBB Securities	Buy → Strong Buy
Mar-12-19	Upgrade	WBB Securities	Speculative Buy → Buy
Jan-26-18	Initiated	Nomura	Buy
Oct-06-17	Initiated	Seaport Global Securities	Buy
Oct-04-17	Reiterated	H.C. Wainwright	Buy
Feb-24-17	Reiterated	FBR & Co.	Outperform
Jul-27-16	Reiterated	FBR Capital	Outperform
Sep-29-15	Initiated	Nomura	Buy
Jul-29-15	Reiterated	ROTH Capital	Buy
Jun-17-15	Reiterated	H.C. Wainwright	Buy
Jun-15-15	Reiterated	ROTH Capital	Buy

View All

Redhill Biopharma Ltd Adr Stock (RDHL) Latest News

Jul 21, 2025

Redhill Biopharma stock soars after FDA provides positive pathway for Crohn’s drug - Investing.com India

Jul 21, 2025

Redhill Biopharma stock soars after FDA provides positive pathway for Crohn’s drug By Investing.com - Investing.com South Africa

Jul 21, 2025

Apr 22, 2025

Taking the lead: Redhill Biopharma Ltd. ADR (RDHL) - Sete News

Apr 22, 2025

The time has not yet come to remove your chips from the table: Hertz Global Holdings Inc (HTZ) - Sete News

Apr 22, 2025

A significant driver of top-line growth: Alexandria Real Estate Equities Inc (ARE) - Sete News

Apr 22, 2025